Search Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupComplicationsDiseaseHearing Loss, Cisplatin InducedSubgroupICD10H91.0MeSHHearing LossSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceSodium ThiosulfateSupportive substanceSodium ThiosulfateSupportive substanceSodium ThiosulfateSupportive substanceSodium ThiosulfateNo. Substances1Protocol classificationTherapy classificationspecial situationIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksHypokalemiaHypomagnesemiaHypophosphatemia only studiesPublicationAuthorBrock PDiseaseHepatoblastom, Erstlinientherapie mit Cisplatin, < 18 JahreOriginBadgers, Tonbridge,United KingdomProtocols in Revision 1 protocol foundProtocols under revision.Sodium Thiosulfate 20, Hearing Loss, Cisplatin Induced (PID1401 V1.0)
